Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis

OO Zaidat, AC Castonguay, BF Fitzsimmons… - Journal of stroke and …, 2013 - Elsevier
Background Patients with high-grade symptomatic intracranial stenosis (≥ 70%) have an
increased risk of recurrent stroke despite medical treatment with antiplatelet or anticoagulant …

Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical …

OO Zaidat, BF Fitzsimmons, BK Woodward, Z Wang… - Jama, 2015 - jamanetwork.com
Importance Intracranial stenosis is one of the most common etiologies of stroke. To our
knowledge, no randomized clinical trials have compared balloon-expandable stent …

Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke

W Yu, WJ Jiang - Stroke and Vascular Neurology, 2018 - svn.bmj.com
Intracranial stenosis is a common cause of ischaemic strokes, in particular, in the Asian,
African and Hispanic populations. The randomised multicentre study Stenting and …

A comparison of stent implant versus medical treatment for severe symptomatic intracranial stenosis: a controlled clinical trial

R Mohammadian, A Pashapour, E Sharifipour… - Cerebrovascular …, 2012 - karger.com
Background: Atherosclerotic stenosis of the major intracranial arteries is the most common
cause of ischemic stroke. There are limited treatments for severe intracranial stenosis, and …

Stenting in intracranial stenosis: current controversies and future directions

AR Chatterjee, CP Derdeyn - Current atherosclerosis reports, 2015 - Springer
Angioplasty and stenting for intracranial atherosclerotic stenosis (ICAS) are a last resort for
patients with high-grade intracranial stenosis with multiple ischemic events unresponsive to …

Comment on: Stenting versus aggressive medical therapy for intracranial arterial stenosis: Chimowitz MI, Lynn MJ, Derdeyn CP, et al. N Engl J Med. 2011; 365: 993 …

H Henkes, H Bäzner, PK Nelson - Clinical neuroradiology, 2011 - Springer
Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke that
is increasingly being treated with percutaneous transluminal angioplasty and stenting …

Does the stenting versus aggressive medical therapy trial support stenting for subgroups with intracranial stenosis?

HL Lutsep, MJ Lynn, GA Cotsonis, CP Derdeyn… - Stroke, 2015 - Am Heart Assoc
Background and Purpose—Although the Stenting Versus Aggressive Medical Therapy for
Intracranial Arterial Stenosis (SAMMPRIS) trial showed that medical therapy alone was …

[HTML][HTML] Stenting versus aggressive medical therapy for intracranial arterial stenosis

MI Chimowitz, MJ Lynn, CP Derdeyn… - … England Journal of …, 2011 - Mass Medical Soc
Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke that
is increasingly being treated with percutaneous transluminal angioplasty and stenting …

Critique of “Stenting Versus Aggressive Medical Therapy for Intracranial Arterial Stenosis” by Chimowitz et al in the New England Journal of Medicine

A Abou-Chebl, H Steinmetz - Stroke, 2012 - Am Heart Assoc
Symptomatic intracranial stenoses are an important cause of stroke and have a high risk of
recurrent stroke with medical therapy. The Stenting and Aggressive Medical Management …

Risk factors associated with in-hospital serious adverse events after stenting of severe symptomatic intracranial stenosis

L Cheng, L Jiao, P Gao, G Song, S Chen… - Clinical Neurology and …, 2016 - Elsevier
Objectives Severe symptomatic intracranial stenosis is an important cause of stroke.
Intracranial stenting is alternatively applied to treat intracranial atherosclerotic disease …